» Articles » PMID: 2525910

Cytotoxicity Mediated by Human Fc Receptors for IgG

Overview
Journal Immunol Today
Date 1989 Mar 1
PMID 2525910
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

The Fc receptors for IgG(Fc gamma R) play a major role in the removal of antibody-coated infectious agents and may be important molecules for triggering cytotoxicity of tumor cells; they may also serve as an entry for infection of Fc gamma R-bearing cells by viral (including HIV and Dengue), and perhaps other infectious agents. Although central to immune defense, an understanding of the role of these Fc gamma R in cytotoxicity has been complicated in part by the presence of several biochemically distinct types of receptor that have different distributions, specificities, affinities and modes of activation for killing. The development of monoclonal antibodies specific for Fc gamma R on human leukocytes has established the existence of three distinct Fc gamma R and furthermore has helped clarify the function of each of these receptors. In this review, Michael Fanger and colleagues discuss the use of Fc gamma R-specific mAb and the hybridoma cell lines that produce them in examining the ability of each of these unique receptors to mediate killing of tumor and red cell targets. In particular, the use of self-directed hybridoma cells as a model of tumor-cell killing and of bi-specific antibodies to link target cells to effector cells through the different Fc gamma R is discussed. The results of these studies suggest that the ability of a given Fc gamma R to trigger killing is sometimes dependent on the type of Fc gamma R, but is also markedly influenced by the type of target cell and by the nature and state of activation of the effector cell.

Citing Articles

Identification of a novel ADCC-related gene signature for predicting the prognosis and therapy response in lung adenocarcinoma.

Zhang L, Zhang X, Guan M, Zeng J, Yu F, Lai F Inflamm Res. 2024; 73(5):841-866.

PMID: 38507067 DOI: 10.1007/s00011-024-01871-y.


B7-H3/CD276 and small-cell lung cancer: What's new?.

Fabrizio F, Muscarella L, Rossi A Transl Oncol. 2023; 39:101801.

PMID: 37865049 PMC: 10728701. DOI: 10.1016/j.tranon.2023.101801.


CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy.

Chang Y, Cai X, Syahirah R, Yao Y, Xu Y, Jin G Nat Commun. 2023; 14(1):2266.

PMID: 37080958 PMC: 10119091. DOI: 10.1038/s41467-023-37872-4.


B7-H3/CD276 Inhibitors: Is There Room for the Treatment of Metastatic Non-Small Cell Lung Cancer?.

Malapelle U, Parente P, Pepe F, Di Micco M, Russo A, Clemente C Int J Mol Sci. 2022; 23(24).

PMID: 36555714 PMC: 9788608. DOI: 10.3390/ijms232416077.


Fc Gamma Receptor IIIB NA1/NA2/SH Polymorphisms Are Associated with Malaria Susceptibility and Antibody Levels to Merozoite Antigens in Beninese Children.

Fall A, Courtin D, Adamou R, Edslev S, Hansen A, Domingo N Int J Mol Sci. 2022; 23(23).

PMID: 36499205 PMC: 9739279. DOI: 10.3390/ijms232314882.